prikaz prve stranice dokumenta Lijekovi za rijetke bolesti
  Download
PDF 843.99 KB
Professional paper - Review paper
Lijekovi za rijetke bolesti
Farmaceutski glasnik, 66 (2010), 6; 325-334. urn:nbn:hr:163:588967
Barbarić, Monika; Meštrović, Martina

Institutional repository: Repository of Faculty of Pharmacy and Biochemistry University of Zagreb

Cite this document

Barbarić, M. & Meštrović, M. (2010). Lijekovi za rijetke bolesti. Farmaceutski glasnik, 66. (6), 325-334. Retrieved from https://urn.nsk.hr/urn:nbn:hr:163:588967

Barbarić, Monika and Martina Meštrović. "Lijekovi za rijetke bolesti." Farmaceutski glasnik, vol. 66, no. 6, 2010, pp. 325-334. https://urn.nsk.hr/urn:nbn:hr:163:588967

Barbarić, Monika and Martina Meštrović. "Lijekovi za rijetke bolesti." Farmaceutski glasnik 66, no. 6 (2010): 325-334. https://urn.nsk.hr/urn:nbn:hr:163:588967

Barbarić, M. and Meštrović, M. (2010) 'Lijekovi za rijetke bolesti', Farmaceutski glasnik, 66(6), pp. 325-334. Available at: https://urn.nsk.hr/urn:nbn:hr:163:588967 (Accessed 05 November 2024)

Barbarić M, Meštrović M. Lijekovi za rijetke bolesti. Farmaceutski glasnik [Internet]. 2010 [cited 2024 November 05];66(6):325-334. Available at: https://urn.nsk.hr/urn:nbn:hr:163:588967

M. Barbarić and M. Meštrović, "Lijekovi za rijetke bolesti", Farmaceutski glasnik, vol. 66, no. 6, pp. 325-334, 2010. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:163:588967. [Accessed: 05 November 2024]

Metadata
Title (croatian)Lijekovi za rijetke bolesti
AuthorMonika Barbarić
AuthorMartina Meštrović
Author's institutionUniversity of Zagreb
Faculty of Pharmacy and Biochemistry
(Department of medicinal chemistry)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Pharmacy
Pharmacy
Abstract (english)
There are between 5000 and 7000 rare diseases. These are often chronic, progressive, degenerative, and often life-threatening diseases. Rare diseases are mostly genetic, and are therefore present throughout the patient's life, even if symptoms do not appear immediately. However, many rare diseases appear early in life, and about 30% of children with rare diseases die before reaching their fifth birthday. There is no cure for most of the rare diseases, so the art of living with a rare disease is an ongoing learning experience for patients and families. »Orphan drugs« are medicinal products intended for the diagnosis, prevention or treatment of life-threatening or debilitating rare diseases. They are »orphans« because the pharmaceutical industry, under normal market conditions, has little interest in developing and marketing drugs intended for only a small number of patients suffering from very rare conditions.
Keywords (croatian)
Languagecroatian
Publication typeProfessional paper - Review paper
Publication statusPublished
Peer reviewPeer review - domestic
Publication versionPublished version
Journal titleFarmaceutski glasnik
Numberingvol. 66, no. 6, pp. 325-334
p-ISSN0014-8202
URN:NBNurn:nbn:hr:163:588967
Publication2010
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2020-09-29 11:19:08